Influences of surface coatings and components of FePt nanoparticles on the suppression of glioma cell proliferation

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3295-3307

  Sun, Haiming ^a   Chen, Xiaohui ^b   Chen, Dan ^a   Dong, Mingyan ^a   Fu, Xinning ^a   Li, Qian ^a   Liu, Xi ^a   Wu, Qingzhi ^a   Qiu, Tong ^a   Wan, Tao ^a   Li, Shipu ^a  

^a Wuhan University of Technology   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Compositions; FePt nanoparticles; Glioma cells; Proliferation; Surface coatings

Indexed keywords

IRON PLATINUM NANOPARTICLE; PLATINUM NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG COATING; DRUG FORMULATION; DRUG UPTAKE; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MITOSIS INHIBITION; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

AMINES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE; GLIOMA; HUMANS; MAGNETITE NANOPARTICLES; OLEIC ACID; PARTICLE SIZE; PLATINUM; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84870363614     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32678     Document Type: Article

References (46)

1. Barbu E, Molnàr E, Tsibouklis J, Górecki DC. The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier. Expert Opin Drug Deliv. 2009;6:553-565.
2. Pardridge WM. Drug and gene delivery to the brain: the vascular route. Neuron. 2002;36:555-558.
3. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today. 2008;13:1099-1106.
4. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5:161-171.
5. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine-challenge and perspectives. Angew Chem Int Ed Engl. 2009;48:872-897.
6. Koo YL, Reddy GR, Bhojani M, etal. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev. 2006;58:1556-1577.
7. Cabada TF, de Pablo CS, Serrano AM, Guerrero Fdel P, Olmedo JJ, Gomez MR. Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Int J Nanomed. 2012;7:1511-1523.
8. Chertok B, David AE, Yang VC. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials. 2010;31:6317-6324.
9. Veiseh O, Sun C, Gunn J, etal. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett. 2005;5:1003-1008.
10. Silva AC, Oliveira TR, Mamani JB, etal. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomed. 2011;6:591-603.
11. Wang ST, Chen KJ, Wu TH, etal. Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells. Angew Chem Int Ed Engl. 2010;49:3777-3781.
12. Rozhkova EA, Ulasov I, Lai B, Dimitrijevic NM, Lesniak MS, Rajh T. A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett. 2009;9:3337-3342.
13. Gao JH, Gu HW, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res. 2009;42:1097-1107.
14. Gu HW, Ho P, Tsang KWT, Yu CW, Xu B. Using biofunctional magnetic nanoparticles to capture gram-negative bacteria at an ultra-low concentration. Chem Commun. 2003;15:1966-1967.
15. Gu HW, Ho P, Tsang KW, Wang L, Xu B. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration. J Am Chem Soc. 2003;125:15702-15703.
16. Xu C, Xu K, Gu H, etal. Nitrilotriacetic acid-modified magnetic nanoparticles as a general agent to bind histidine-tagged proteins. J Am Chem Soc. 2004;126:3392-3393.
17. Hong R, Fischer NO, Emrick T, Rotello VM. Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications. Chem Mater. 2005;17:4617-4621.
18. Chiang PC, Hung DS, Wang JW, Ho CS, Yao YD. Engineering water-dispersible FePt nanoparticles for biomedical applications. IEEE Trans Magn. 2007;43:2445-2447.
19. Gao J, Liang G, Cheung JS, etal. Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. J Am Chem Soc. 2008;130:11828-11833.
20. Chen S, Wang LJ, Duce SL, etal. Engineering biocompatible nanoparticles for in vivo imaging applications. J Am Chem Soc. 2010;132:15022-15029.
21. Chou SW, Shau YH, Wu PC, Yang YS, Shieh DB, Chen CC. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc. 2010;132:13270-13278.
22. Yang H, Zhang JJ, Tian QW, etal. One-pot synthesis of amphiphilic superparamagnetic FePt nanoparticles and magnetic resonance imaging in vitro. J Magn Magn Mater. 2010;322:973-977.
23. Gao J, Liang L, Zhang B, Kuang Y, Zhang X, Xu B. FePt@CoS2 yolk-shell nanocrystals as a potent agent to kill HeLa cells. J Am Chem Soc. 2007;129:1428-1433.
24. Xu C, Yuan Z, Kohler N, Kim J, Chung MA, Sun S. FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition. J Am Chem Soc. 2009;131:15346-15351.
25. Elkins KE, Vedantam TS, Liu JP, etal. Ultrafine FePt nanoparticles prepared by the chemical reduction method. Nano Lett. 2003;3:1647-1649.
26. Saita S, Maenosono S. Formation mechanism of FePt nanoparticles synthesized via pyrolysis of iron (III) ethoxide and platinum (II) acetylacetonate. Chem Mater. 2005;17:6624-6634.
27. Teng X, Yang H. Synthesis of magnetic nanocomposites and alloys from platinum-iron oxide core-shell nanoparticles. Nanotechnology. 2005;16:S554-S561.
28. Loc Nguyen H, Howard LEM, Stinton GW, etal. Synthesis of size-Controlled fcc and fct FePt nanoparticles. Chem Mater. 2006;18:6414-6424.
29. Monnier V, Delalande M, Bayle Guillemaud P, Samson Y, Reiss P. Synthesis of homogeneous FePt nanoparticles using a nitrile ligand. Small. 2008;4:1139-1142.
30. Srivastava C, Balasubramanian J, Turner CH, Wiest JM, Bagaria HG, Thompson GB. Formation mechanism and composition distribution of FePt nanoparticles. J Appl Phys. 2007;102:104310-1-104310-8.
31. Stahl B, Gajbhiye NS, Wilde G, etal. Electronic and magnetic properties of monodispersed FePt nanoparticles. Adv Mater. 2002;14:24-27.
32. Sun S, Anders S, Thomson T, etal. Controlled synthesis and assembly of FePt nanoparticles. J Phys Chem B. 2003;107:5419-5425.
33. Suda M, Nakagawa M, Lyoda T, Einaga Y. Reversible photoswitching of ferromagnetic FePt nanoparticles at room temperature. J Am Chem Soc. 2007;129:5538-5543.
34. Salgueiriño-Maceira V, Liz-Marzán LM, Farle M. Water-based ferrofluids from FexPt1-x nanoparticles synthesized in organic media. Langmuir. 2004;20:6946-6950.
35. Lai CW, Wang YH, Uttam BP, etal. One-pot solvothermal synthesis of FePt/Fe3O4 core-shell nanoparticles. Chem Commun (Camb). 2008;14:5342-5344.
36. Wu Q, Cao H, Luan Q, etal. Biomolecule-assisted synthesis of water-soluble silver nanoparticles and their biomedical applications. Inorg Chem. 2008;47:5882-5888.
37. Lehmann AD, Parak SJ, Zhang F, etal. Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammary response in lung cells in vitro correlated with intracellular localization. Small. 2010;6:753-762.
38. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell Iinteractions. Small. 2010;6:12-21.
39. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145-150.
40. Cho EC, Au L, Zhang Q, Xia Y. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small. 2010;6:517-522.
41. Verma A, Uzun O, Hu Y, etal. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2008;7:588-595.
42. Cho EC, Zhang Q, Xia Y. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol. 2011; 6:385-391.
43. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4:26-49.
44. Bhabra G, Sood A, Fisher B, etal. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol. 2009;4:876-883.
45. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol. 2009;4:634-641.
46. Puzyn T, Rasulev B, Gajewicz A, etal. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol. 2011;6:175-178.